Reverse Medical Receives FDA Clearance for Intracranial Catheter

Reverse Medical Receives FDA Clearance for Intracranial Catheter

04/27/2011

Irvine, CA--Reverse Medical Corporation announced today that it has received U.S. FDA 510k clearance to market the ReFlex(TM) line of intracranial catheters for distal neurovascular access and microcatheter therapeutic delivery. Read more...

Find Out More About ESP

Staff Photo

Managing Director Mike Bunker manages the Reverse Medical Corporation investment for Early Stage Partners